Page 62 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

204. Liu Y, Nguyen M, Robert A, Meunier B. Metal ions in mitochondrial therapy in Alzheimer’s disease. ACS
Alzheimer’s disease: A key role or not? Acc Chem Res. Nano. 2022;16(7):11455-11472.
2019;52(7):2026-2035.
doi: 10.1021/acsnano.2c05795
doi: 10.1021/acs.accounts.9b00248
215. Kwon HJ, Cha MY, Kim D, et al. Mitochondria-targeting
205. Gaggelli E, Kozlowski H, Valensin D, Valensin G. Copper ceria nanoparticles as antioxidants for Alzheimer’s disease.
homeostasis and neurodegenerative disorders (Alzheimer’s, ACS Nano. 2016;10(2):2860-2870.
prion, and Parkinson’s diseases and amyotrophic lateral doi: 10.1021/acsnano.5b08045
sclerosis). Chem Rev. 2006;106(6):1995-2044.
216. Zeng F, Wu Y, Li X, et al. Custom-made ceria nanoparticles
doi: 10.1021/cr040410w show a neuroprotective effect by modulating phenotypic
206. Hardy J, Allsop D. Amyloid deposition as the central event polarization of the microglia. Angew Chem Int Ed Engl.
in the aetiology of Alzheimer’s disease. Trends Pharmacol 2018;57(20):5808-5812.
Sci. 1991;12(10):383-388. doi: 10.1002/anie.201802309
doi: 10.1016/0165-6147(91)90609-v 217. Chen Q, Du Y, Zhang K, et al. Tau-targeted multifunctional
207. Kepp KP. Bioinorganic chemistry of Alzheimer’s disease. nanocomposite for combinational therapy of Alzheimer’s
Chem Rev. 2012;112(10):5193-5239. disease. ACS Nano. 2018;12(2):1321-1338.
doi: 10.1021/cr300009x doi: 10.1021/acsnano.7b07625
208. Huang X, Atwood CS, Hartshorn MA, et al. The A beta 218. Cai X, Zhang K, Xie X, et al. Self-assembly hollow
peptide of Alzheimer’s disease directly produces hydrogen manganese Prussian white nanocapsules attenuate Tau-
peroxide through metal ion reduction. Biochemistry. related neuropathology and cognitive decline. Biomaterials.
1999;38(24):7609-7616. 2020;231:119678.
doi: 10.1021/bi990438f doi: 10.1016/j.biomaterials.2019.119678
209. Huang X, Cuajungco MP, Atwood CS, et al. Cu(II) 219. Gao N, Dong K, Zhao AD, et al. Polyoxometalate-based
potentiation of Alzheimer abeta neurotoxicity. Correlation nanozyme: Design of a multifunctional enzyme for
with cell-free hydrogen peroxide production and metal multi-faceted treatment of Alzheimer’s disease. Nano Res.
reduction. J Biol Chem. 1999;274(52):37111-3716. 2016;9(4):1079-1090.
doi: 10.1074/jbc.274.52.37111 doi: 10.1007/s12274-016-1000-6
210. Mondragon-Rodriguez S, Perry G, Zhu X, Moreira PI, 220. Lotharius J, Brundin P. Pathogenesis of Parkinson’s disease:
Acevedo-Aquino MC, Williams S. Phosphorylation Dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci.
of tau protein as the link between oxidative stress, 2002;3(12):932-942.
mitochondrial dysfunction, and connectivity failure: doi: 10.1038/nrn983
Implications for Alzheimer’s disease. Oxid Med Cell
Longev. 2013;2013:940603. 221. Gerard C, Chehhal H, Hugel RP. Complexes of iron(III)
with ligands of biological interest: Dopamine and
doi: 10.1155/2013/940603 8-hydroxyquinoline-5-sulphonic acid. Polyhedron.
211. Reisberg B, Doody R, Stoffler A, et al. Memantine in 1994;13(4):541-597.
moderate-to-severe Alzheimer’s disease. N Engl J Med. doi: 10.1016/s0277-5387(00)84736-1
2003;348(14):1333-1341.
222. Sulzer D, Bogulavsky J, Larsen KE, et al. Neuromelanin
doi: 10.1056/NEJMoa013128 biosynthesis is driven by excess cytosolic catecholamines
212. Zhang L, Zhao P, Yue C, et al. Sustained release of bioactive not accumulated by synaptic vesicles. Proc Natl Acad Sci U
hydrogen by Pd hydride nanoparticles overcomes S A. 2000;97(22):11869-11874.
Alzheimer’s disease. Biomaterials. 2019;197:393-404. doi: 10.1073/pnas.97.22.11869
doi: 10.1016/j.biomaterials.2019.01.037 223. Double KL, Gerlach M, Schunemann V, et al. Iron-binding
213. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. characteristics of neuromelanin of the human substantia
Mitochondrial bioenergetic deficit precedes Alzheimer’s nigra. Biochem Pharmacol. 2003;66(3):489-494.
pathology in female mouse model of Alzheimer’s disease. doi: 10.1016/s0006-2952(03)00293-4
Proc Natl Acad Sci U S A. 2009;106(34):14670-14675.
224. Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ.
doi: 10.1073/pnas.0903563106 A role for alpha-synuclein in the regulation of dopamine
biosynthesis. J Neurosci. 2002;22(8):3090-3099.
214. Qian K, Bao X, Li Y, et al. Cholinergic neuron targeting
nanosystem delivering hybrid peptide for combinatorial doi: 10.1523/JNEUROSCI.22-08-03090.2002

Volume 1 Issue 1 (2024) 56 doi: 10.36922/imo.2527